D7135

Smith & Nephew is a globally renowned medical equipment manufacturing company, specializing in the design, development, and distribution of advanced medical devices and technologies. Founded in 1856 in Hull, England, by Thomas James Smith, the company initially started as a small pharmacy but has since evolved into a leading player in the healthcare industry. Today, Smith & Nephew operates in over 100 countries and is publicly traded on the London Stock Exchange under the symbol SN.

The company's mission is to restore people's bodies and their self-belief by using technology to take the limits off living. This mission drives Smith & Nephew to innovate continuously and provide effective solutions that improve the quality of life for patients around the world. The company focuses on three main business areas: Orthopaedics, Sports Medicine, and Advanced Wound Management.

In Orthopaedics, Smith & Nephew provides an extensive range of products, including joint replacement systems for knees, hips, and shoulders, as well as robotics-assisted enabling technologies and trauma products for the repair of fractures and deformity correction procedures. Their orthopaedic products are designed to be durable, functional, and highly effective, catering to the varying needs of patients and surgeons.

The Sports Medicine segment offers solutions to repair soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. Smith & Nephew's innovative products in this area include minimally invasive surgical instruments, advanced arthroscopy equipment, and biocompatible materials for tissue repair, which help athletes and active individuals return to their activities faster.

Advanced Wound Management is another critical area for Smith & Nephew, where they provide a comprehensive line of products designed to treat acute and chronic wounds. Their portfolio includes advanced wound dressings, negative pressure wound therapy systems, and wound care products that promote faster healing and reduce the risk of infection. These products are crucial for managing complex wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Smith & Nephew is committed to research and development, investing heavily in new technologies and innovations to address the evolving needs of the healthcare sector. The company collaborates with healthcare professionals and academic institutions worldwide to develop products that are both clinically effective and economically viable.

Sustainability and corporate responsibility are integral to Smith & Nephew's business philosophy. The company strives to minimize its environmental impact and operates under strict ethical standards to ensure that its practices benefit all stakeholders, including patients, employees, communities, and shareholders.

With a rich history spanning over 160 years, Smith & Nephew continues to be at the forefront of medical technology, providing products and services that improve health outcomes and enhance the lives of people around the world. Their dedication to innovation, quality, and patient care has established them as a trusted leader in the medical device industry.